A Mark of Success?

Name: A Mark of Success?
Uploaded: 2019-04-29T17:47:05+00:00
Description: Achim Schneeberger, MD, talks about the Phase II study that demonstrated clinical and biomarker effects consistent with disease modification in Alzheimer's

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Diagnosis and Management of Dementia and Psychosis in Individuals With Parkinson Disease
Diagnosis and Management of Dementia and Psychosis in Individuals With Parkinson Disease
Movement Disorders
Diagnosis and Management of Dementia and Psychosis in Individuals With Parkinson Disease
Jorge Patino, MD
Jorge Patino, MD
How to Communicate the Results of Alzheimer Disease Biomarker Tests with Patients
How to Communicate the Results of Alzheimer Disease Biomarker Tests with Patients
Neurology in Motion
How to Communicate the Results of Alzheimer Disease Biomarker Tests with Patients
Suzanne E. Schindler, MD, PhD
Suzanne E. Schindler, MD, PhD
Factors Influencing the Selection of Blood Tests for Alzheimer Disease
Factors Influencing the Selection of Blood Tests for Alzheimer Disease
Neurology in Motion
Factors Influencing the Selection of Blood Tests for Alzheimer Disease
Suzanne E. Schindler, MD, PhD
Suzanne E. Schindler, MD, PhD
Presentation and Management of Psychosis, Depression, Agitation, Apathy, and RBD in People Living with Lewy Body Dementia
Presentation and Management of Psychosis, Depression, Agitation, Apathy, and RBD in People Living with Lewy Body Dementia
AUG 2025 ISSUE
Presentation and Management of Psychosis, Depression, Agitation, Apathy, and RBD in People Living with Lewy Body Dementia
Poorva Sheth, BS; Avrie Barthel, BS
Poorva Sheth, BS; Avrie Barthel, BS

PODCASTS

VIDEOS

COLUMNS

MEDICAL NEWS

A Mark of Success?

Recommended

A Mark of Success?

Recommended

Title

Share on ReachMD

Get a Dose of Practical Neurology in Your Inbox and Practice Smarter Medicine